P ressure-derived fractional flow reserve (FFR) is the reference standard in catheterization laboratories to assess the physiological severity of coronary artery stenosis.
Influence of Contrast Dose and Osmolality on cFFR
coronary angiography and does not require special software or an ECG tracing. 15, 16 However, there is a theoretical concern that both contrast dose and osmolality may affect the degree of hyperemia and therefore the diagnostic performance achieved with cFFR. In clinical practice, the type and dose of contrast media used for cardiac catheterization varies.
We, therefore, performed this analysis to investigate the impact of contrast osmolality and dose on the diagnostic performance of cFFR.
Methods

Study Design and Population
The CONTRAST study (Can Contrast Injection Better Approximate FFR Compared ToPure Resting Physiology?) 16 is a multicenter, prospective, investigator-initiated observational study designed to evaluate the diagnostic performance of contrast FFR (cFFR), resting distal coronary pressure to aortic or proximal coronary pressure (Pd/Pa), and the instantaneous wave-free ratio (iFR) to predict FFR.
The current study enrolled 763 patients from the CONTRAST study who were ≥18 years of age and underwent routine FFR assessment for standard indications. In cases of multivessel disease, only the first lesion studied using FFR was included. Exclusion criteria included previous coronary artery bypass surgery, known severe left ventricular hypertrophy (septal wall thickness >13 mm) or dysfunction (left ventricular ejection fraction <30%), extremely tortuous or calcified coronary arteries precluding intracoronary physiological measurement, contraindication to adenosine, recent (within 3 weeks before cardiac catheterization) ST-segment-elevation myocardial infarction, or renal insufficiency such that additional contrast would pose unwarranted risk. Culprit lesions for acute infarction were also excluded. This study was approved by an institutional review committee from each participating site, and each patient provided written informed consent.
Coronary Physiology Procedure
All coronary physiological parameters were measured with a 0.014-inch pressure sensor guidewire (PressureWire Certus or Aeris wire and the QUANTIEN system; St. Jude Medical). The pressure guidewire was advanced distal to the target lesion. The first measurements were made for at least 1 minute to record resting physiology. Next, an intracoronary bolus of contrast medium was injected either manually or with an injector. The volume and type of intracoronary contrast medium was not mandated but with a recommendation for 6 to 10 mL. Then, 100 to 200 μg of intracoronary adenosine was injected. 17 Finally, intravenous adenosine was administered at 140 μg/kg per minute for 2 minutes via either a central or large-bore peripheral intravenous line. Each measurement was repeated twice in the same way with at least a 1-minute interval to ensure pressure recovery. Operators were encouraged to perform both intracoronary and intravenous adenosine measurements in duplicate, but all 4 were not mandatory as long as at least 1 technique was repeated. All physiological tracings were sent to an independent core laboratory (Cardiovascular Research Foundation, New York) for off-line analysis. The quality of pressure tracings and electrocardiographic
WHAT IS KNOWN
• The pressure ratio between the distal coronary artery and aorta during submaximal hyperemia induced by intracoronary injection of contrast medium, socalled contrast fractional flow reserve (cFFR), has been shown to be superior to other adenosine-free indices obtained at rest, such as the instantaneous wave-free ratio and the distal pressure/aortic pressure, in predicting fractional flow reserve and reducing the use of adenosine.
WHAT THE STUDY ADDS
• The results of the current study further confirm the superiority of cFFR, showing that cFFR has better diagnostic accuracy than instantaneous wave-free ratio and distal pressure/aortic pressure regardless of key variables in the performance of cFFR, namely, the contrast media volume administered and the contrast media osmolality.
• Both contrast media volume and osmolality affect sensitivity and specificity of cFFR, but in opposite directions such that the overall diagnostic accuracy is not different between low and high contrast volume injection or between low-and iso-osmolar contrast agents. data were carefully evaluated. FFR was measured as mean distal coronary pressure divided by aortic or proximal coronary pressure during maximal hyperemia with intracoronary injection and intravenous infusion of adenosine, cFFR was measured during submaximal hyperemia with intracoronary injection of contrast, and Pd/Pa was measured at rest. The iFR was defined as the ratio of distal coronary pressure to aortic pressure during the wave-free period (≈75% of late diastole) at rest, 8 automatically calculated by the core laboratory using HARVEST software (Volcano Corporation). Because there could be as many as 4 FFR values for each subject (2 intracoronary and 2 intravenous), a summary FFR value was computed by the following hierarchy: the average of 2 intravenous values, a single intravenous value, the average of 2 intracoronary values, or a single intracoronary value. When both test and retest values were present, their average was used.
Study End Points
The primary purpose of this analysis was to investigate whether the osmolality and dose of contrast media impact the diagnostic performance of cFFR. The patients were categorized by the osmolality of contrast media used for cFFR measurement into 2 groups: lowosmolality (including iobitridol, iohexol, iomeprol, iopamidol, iopromide, ioversol, and ioxaglate) and iso-osmolality group (including iodixanol) and by the median value of contrast volume: high contrast volume (≥8 mL) and low contrast volume (<8 mL).
The significance of a coronary artery lesion based on adenosine-free indices was defined as cFFR ≤0.83, iFR <0.90, and Pd/ Pa <0.92 according to previous studies. 10, 16 We explored the diagnostic performance of the hybrid strategy in which adenosine can be avoided for values above or below a defined threshold but must be administered when the value falls within those limits (adenosine zone). The range of 0.83 to 0.88, 0.87 to 0.94, and 0.89 to 0.95 was chosen for cFFR, iFR, and Pd/Pa, respectively, adenosine zone as used to achieve 94% rounded overall accuracy in CONTRAST study cohort. 16 
Statistical Analysis
Continuous variables are presented as a median and interquartile range and were compared with Mann-Whitney U test. Categorical variables are presented as counts and percentages and were compared using the Fisher exact test. Correlations between FFR and adenosine-free indices were tested with Pearson correlation coefficient. ROC curve analysis was used to examine the diagnostic performance of cFFR, iFR, and Pd/Pa as a predictor of FFR ≤0.80. The area under the ROC curve was compared with the method of DeLong et al 18 or Hanley and McNeil 19 for correlated or uncorrelated curves. Multivariable logistic regression models were used to assess whether contrast osmolality and volume were predictors of diagnostic performance of cFFR. In the models, the diagnostic agreement between cFFR and FFR (agreement or not) in positive FFR, negative FFR, and entire patients were used as a dependent variable for sensitivity, specificity, and overall accuracy, respectively, whereas contrast osmolality (iso versus low osmolality) and volume (high versus low volume) were used for independent variables. Statistical analysis was performed using SAS version 9.4 (SAS Institute, Cary, NC). Value of P<0.05 was considered significant.
Results
Patient characteristics are presented in Tables 1 and 2 . There were 574 patients in the low-osmolality group versus 189 patients in the iso-osmolality group and 341 patients in the low contrast volume group versus 422 patients in the high contrast volume group. The median intracoronary contrast volume was similar in the low-and iso-osmolality groups (8 [6-8] versus 8 [6-10] mL; P=0.12). Iso-osmolality contrast was more frequently used in patients with advanced age, renal insufficiency, female sex, and dyslipidemia. Low contrast volume was more frequently used in patients with advanced age, female sex, hypertension, diabetes mellitus, and dyslipidemia but without family history of coronary artery disease. The cFFR value was lower in the iso-osmolality group than in the low-osmolality group. Pd/Pa, iFR, and FFR values were not significantly different between the 2 osmolality groups ( Table 3 ). The Pd/Pa, iFR, and cFFR values were higher in the low contrast volume group than in the high contrast volume group. The FFR value was not significantly different between the low and high contrast volume groups (Table 4) .
Correlation and Agreement Between the AdenosineFree Indices and FFR
cFFR correlated well with FFR in both low-and iso-osmolality groups, as well as in both low and high contrast volume groups. Among the 3 adenosine-free indices, cFFR showed the highest correlation coefficient with FFR (Figures 1 and   2 ) and the best agreement with FFR with the smallest scatter of data by the Bland-Altman Plots (Figures 3 and 4 ) in all groups.
Comparisons of Diagnostic Performance of the Adenosine-Free Indices
The results of the ROC analysis of cFFR, iFR, and Pd/Pa to predict FFR ≤0.80 are shown in Figures 5 and 6 . When comparing area under the ROC curve, cFFR provided better diagnostic performance than resting indices regardless of contrast osmolality or volume (P<0.001 versus iFR and Pd/Pa for all groups). There was no significant difference between the area under the ROC curve of cFFR in the low-and iso-osmolality groups (0.938 versus 0.957; P=0.40) and in the low and high contrast volume groups (0.939 versus 0.949; P=0.61).
Application of Binary Strategies and Effect of Contrast Osmolality and Volume
When using a binary strategy with a defined threshold of cFFR ≤0.83, low-osmolality contrast had lower sensitivity and slightly higher specificity than iso-osmolality contrast, as did low contrast volume compared with high contrast volume ( Table 5 ). Multivariable logistic regression models showed that contrast osmolality and volume independently affected sensitivity and specificity of cFFR (Table 6 ). Sensitivity was likely to increase, and specificity was likely to decrease as contrast volume increased or iso-osmolar contrast was used Values are median (interquartile range). cFFR indicates contrast-based fractional flow reserve; FFR, fractional flow reserve; iFR, instantaneous wavefree ratio; and Pd/Pa, distal pressure/aortic pressure. Influence of Contrast Dose and Osmolality on cFFR (versus low osmolar). However, the overall diagnostic accuracy of cFFR was not significantly affected by contrast volume and osmolality.
Application of Hybrid Strategies
When using a hybrid strategy, the overall accuracy of cFFR-FFR hybrid strategy achieved similarly high values of 94.9% and 95.3% in the low-and iso-osmolality and 94.4% and 95.4% in the low and high contrast volume groups with high sensitivity (91.4% and 97.4% in the low-and iso-osmolality and 89.7% and 95.4% in the low and high contrast volume groups) and high specificity (98.4% and 93.6% in the lowand iso-osmolality and 95.4% and 99.3% in the low and high contrast volume groups). Furthermore, the percentages of patients requiring adenosine were <30% in all groups: 25.5% and 28.4% in the low-and iso-osmolality and 22.4% and 29.4% in the low and high contrast volume groups. On the other hand, 42.8% or 46.0% of patients needed adenosine for iFR-FFR or Pd/Pa-FFR hybrid strategies, respectively. Multivariable logistic regression revealed that neither contrast osmolality (odds ratio, 
Discussion
The main finding of this study is that the overall accuracy of cFFR in comparison to FFR is not affected by contrast osmolality or volume. cFFR has better diagnostic performance than iFR and Pd/Pa regardless of whether low-or iso-osmolar contrast is used and whether low or high contrast volume is injected. Both contrast osmolality and volume do affect sensitivity and specificity of cFFR, but in opposite directions such that the overall diagnostic accuracy is not different between the low-or iso-osmolar agents or between low-or highvolume injection.
Previous studies have shown that cFFR has greater overall accuracy than other resting adenosine-free indices; however, the contrast osmolality and volume used to measure cFFR in those studies varied. [13] [14] [15] [16] In theory, both contrast osmolality and volume injected might affect the degree of hyperemia achieved when measuring cFFR and therefore impact its diagnostic performance. 20, 21 The mechanism by which contrast media induce submaximal hyperemia is not entirely clear but presumed to be partially because of transient hypoxia from replacement of oxygenated blood and partially because of stimulating endothelial paracrine pathways. 
Influence of Contrast Dose and Osmolality on cFFR
In the present study, greater contrast volume and lower osmolality were associated with an increase in sensitivity and a decrease in specificity, which may mean that higher contrast volume and lower osmolar contrast result in greater hyperemia. With respect to the hyperemic effect of contrast osmolality, one might think that higher osmolar contrast would be more hyperemic; however, iodixanol, an iso-osmolar contrast (lower osmolality than low-osmolar contrast agents), has higher viscosity than the low-osmolality contrast media, 22 which might contribute to its greater hyperemia because viscosity of the contrast media directly influences the endothelium-derived vasodilatory response of the coronary vasculature and therefore the degree of hyperemia. 23 Previous studies have investigated the influence of contrast dose on contrast-induced hyperemia, but mostly using older contrast agents different from contemporary, lower osmolar contrast. 21, 24 A recent study tested progressive contrast doses (3, 6, 10, and 15 mL) of iodixanol in 12 left coronary lesions, showing that the percentage of cFFR relative to Pd/Pa decreased as contrast dose increased from 3, 6 to 10 mL. 14 The result was in line with our study, suggesting the presence of a dose-response relationship between contrast volume and degree of contrast-induced hyperemia in the dose range typically used during coronary angiography. Although the overall diagnostic accuracy of cFFR did not change based on the volume or osmolality of the contrast media injected, Table 4 shows that the sensitivity of cFFR was higher in patients receiving higher contrast volume, whereas specificity was lower. Likewise, the sensitivity of cFFR was higher in patients receiving iso-osmolar contrast than in those receiving low-osmolar contrast. It is important to note that the same patients were not randomized to high or low contrast volume or to low-or iso-osmolar contrast. For this reason, the patients who received higher volumes of contrast were different from those who received lower volume contrast, for example, and these differences contribute to the changes in sensitivity and specificity that were observed.
Because the relationship between sensitivity and specificity is a trade-off relation, our threshold of cFFR≤0.83 maximizes overall accuracy but does not maximize either just sensitivity or just specificity. Another method of using cFFR simply applies the FFR threshold, namely, cFFR≤0.80. In this case, cFFR theoretically reaches 100% specificity (all FFR negative lesions are cFFR negative) but with reduced sensitivity (cFFR may be negative in some FFR-positive lesions). Therefore the differences in sensitivity and specificity represent tradeoffs on the ROC curve, which different operators may weight differently (a rulein versus rule-out threshold) from our choice to maximize overall accuracy. Although contrast volume and osmolality affect the sensitivity and specificity of cFFR because these parameters change in opposite directions the overall diagnostic performance of the binary strategy of cFFR is not affected to a great degree by contrast volume injected or osmolality. However, because contrast volume and osmolality have an effect on sensitivity and specificity, contrast volume and osmolality become relevant in specific circumstances. For example, if one is most interested in achieving a high sensitivity, then a higher contrast volume and a lower osmolality will increase the sensitivity of cFFR. Likewise, if one is most interested in achieving a high specificity, then a lower contrast volume and a higher osmolality will increase the specificity of cFFR. Receiver operator characteristics curve analysis of adenosine-free indices to predict fractional flow reserve (FFR) ≤0.80 in lowand iso-osmolality contrast groups. The area under the receiver operating characteristic curve (AUC) of contrast-based FFR (cFFR) was the greatest among the adenosine-free indices in both low-and iso-osmolality group (all P<0.001). There was no significant difference between the AUC of cFFR in the low-and iso-osmolality group (P=0.40). CI indicates confidence interval; iFR, instantaneous wave-free ratio; and Pd/Pa, distal pressure/aortic pressure at rest.
It is challenging to determine the reason for the lower cFFR in patients receiving higher volume of contrast (Table 4) . At first glance, one might conclude that this is a result of greater hyperemia with a larger volume of contrast. However, unfortunately patients were not randomized to lower or higher volumes of contrast, which means that we cannot assume the difference is because of a greater hyperemic effect in patients receiving a higher volume of contrast, because it may be because of the significant differences in baseline characteristics between the 2 groups ( Table 2 ). For example, there were significantly more diabetic, hypertensive, dyslipidemic, and female patients who received a lower volume of contrast. All of these clinical characteristics have been associated with microvascular dysfunction; this may explain the higher cFFR value in the patients who received the lower volume of contrast. It may also explain the significantly higher Pd/Pa and iFR seen in the low contrast volume group compared with the high contrast volume group, differences that clearly are not related to contrast volume. Why FFR did not change as well may be because of higher resting flow in the patients who received high contrast volume, which could explain the lower values recorded with the adenosine-free indices. Once adenosine is administered, it abolishes any contribution of resting flow and FFR values may therefore be no different between the 2 groups.
With respect to the higher cFFR seen in the low osmolality group compared with the iso-osmolality group (Table 3) , again we cannot assume that this is because of an effect of the osmolality. This is because the patients were not randomized to low-osmolality or iso-osmolality contrast and therefore, as mentioned above, differences in baseline clinical characteristics might explain the difference in cFFR.
As FFR is the reference standard, a binary strategy of cFFR during submaximal hyperemia achieved an overall accuracy of 85% to 90%. [13] [14] [15] [16] Using a cFFR-FFR hybrid strategy can raise the overall accuracy to ≈95%. [13] [14] [15] [16] The present study showed that the hybrid strategy avoids adenosine in >70% of patients with a minimal effect of contrast osmolality and volume on sensitivity and specificity.
Limitations
Our study has several limitations. First, the present study is a nonrandomized, post hoc analysis of the CONTRAST Figure 6 . Receiver operator characteristics curve analysis of adenosine-free indices to predict fractional flow reserve (FFR) ≤0.80 in the low and high contrast volume groups. The receiver operating characteristic curve (AUC) of contrast-based FFR (cFFR) was the greatest among the adenosine-free indices in both low and high contrast volume groups (all P<0.001). There was no significant difference between the AUC of cFFR in the low-and iso-osmolality groups (P=0.61). CI indicates confidence interval; iFR, instantaneous wave-free ratio; and Pd/Pa, distal pressure/aortic pressure at rest. study. Therefore, the results should be interpreted as hypothesis generating. A randomized study comparing volume and osmolality of contrast media injected in the same patients would help to clarify whether any real differences exist in overall accuracy, as well as sensitivity and specificity of cFFR. Second, we did not investigate the impact of the differences in other factors of contrast media such as pH or ionicity. Third, because the cutoff values for both binary and hybrid strategies are derived from the CONTRAST study, the reproducibility of the results should be evaluated in other cohorts. Fourth, contrast volume between 6 and 10 mL was used in ≈98% of cases in the CONTRAST study, thus the result of this study cannot be extrapolated to smaller or larger contrast volume. Fifth, because the protocol did not stipulate that operators measure the exact amount of contrast used with each cFFR measurement, but asked operators to provide an estimate of the contrast volume, there is some degree of uncertainty surrounding the volume administered. Finally, the overall accuracy is influenced by disease prevalence (ie, in this study, the prevalence of positive FFR [≤0.80]). However, as the prevalence of positive FFR was similar between iso-and low-osmolality groups, we used the models for overall accuracy to look at the effect of osmolality and volume on the overall accuracy of cFFR.
Conclusions
Neither contrast volume nor osmolality significantly affect the overall diagnostic accuracy of cFFR. cFFR should be broadly applicable in clinical practice when operators prefer to avoid adenosine for physiological lesion assessment. However, contrast volume and osmolality affect the sensitivity and specificity of cFFR; greater contrast volume and iso-osmolality were associated with an increase in sensitivity and a decrease in specificity. Therefore, if one is most interested in achieving either high sensitivity alone or high specificity alone for cFFR, then contrast volume and osmolality are important.
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